MicroRNA-379 suppresses cervical cancer cell proliferation and invasion by directly targeting V-crk avian sarcoma virus CT10 oncogene homolog-like.
By: Xi Shi, Na Yuan, Shili Zhang, Fukang Yuan, Xiaohong Wang

Institute of Audiology and Balance Science, Xuzhou Medical University, Xuzhou 221004, China.
2018-1-4; doi: 10.3727/096504017X15140534417184
Abstract

Cervical cancer is the fourth most common malignancy among females worldwide. MicroRNA-379 (miR-379) is aberrantly expressed in multiple human cancer types. However, the expression pattern, roles and detailed regulatory mechanisms of miR-379 in cervical cancer remain unknown. In this study, we found that miR-379 expression was downregulated in cervical cancer tissues and cell lines. Low miR-379 expression was correlated with International Federation of Gynecology and Obstetrics (FIGO) stage, lymph node metastasis and distant metastasis. Additionally, miR-379 overexpression suppressed the proliferation and invasion of cervical cancer cells. Furthermore, V-crk avian sarcoma virus CT10 oncogene homolog-like (CRKL) was identified as direct target of miR-379 in cervical cancer. CRKL was upregulated in cancer tissues and negatively correlated with miR-379 expression. Moreover, restored CRKL expression rescued the inhibitory effects of miR-379 overexpression on cell proliferation and invasion. In conclusion, miR-379 may serve as a tumour suppressor in cervical cancer by directly targeting CRKL. Restoring miR-379 expression may be an effective strategy for treatment of cervical cancer.





PMID:29295725






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements